These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
466 related items for PubMed ID: 30608951
61. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B, Jia L. J Hematol Oncol; 2018 Jul 03; 11(1):89. PubMed ID: 29970122 [Abstract] [Full Text] [Related]
62. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients. Ak S, Tunca B, Tezcan G, Cecener G, Egeli U, Yilmazlar T, Ozturk E, Yerci O. J Surg Res; 2014 Sep 03; 191(1):113-22. PubMed ID: 24746948 [Abstract] [Full Text] [Related]
63. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Li W, Chang J, Wang S, Liu X, Peng J, Huang D, Sun M, Chen Z, Zhang W, Guo W, Li J. Oncotarget; 2015 Sep 15; 6(27):24448-62. PubMed ID: 26259252 [Abstract] [Full Text] [Related]
64. Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome. Rai A, Greening DW, Chen M, Xu R, Ji H, Simpson RJ. Proteomics; 2019 Apr 15; 19(8):e1800148. PubMed ID: 30582284 [Abstract] [Full Text] [Related]
65. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer. Feng C, Zhang L, Sun Y, Li X, Zhan L, Lou Y, Wang Y, Liu L, Zhang Y. Biomed Pharmacother; 2018 May 15; 101():945-952. PubMed ID: 29635904 [Abstract] [Full Text] [Related]
66. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study. Mercadal M, Herrero C, López-Rodrigo O, Castells M, de la Fuente A, Vigués F, Bassas L, Larriba S. Int J Mol Sci; 2020 Aug 19; 21(17):. PubMed ID: 32824915 [Abstract] [Full Text] [Related]
67. Dysregulated genes and miRNAs in the apoptosis pathway in colorectal cancer patients. Slattery ML, Mullany LE, Sakoda LC, Wolff RK, Samowitz WS, Herrick JS. Apoptosis; 2018 Apr 19; 23(3-4):237-250. PubMed ID: 29516317 [Abstract] [Full Text] [Related]
68. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Tokarz P, Blasiak J. Acta Biochim Pol; 2012 Apr 19; 59(4):467-74. PubMed ID: 23173124 [Abstract] [Full Text] [Related]
69. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer. Wang H, Zhang J, Tian J, Qu B, Li T, Chen Y, Liu J, Wang S. J Nucl Med; 2009 Nov 19; 50(11):1857-64. PubMed ID: 19837754 [Abstract] [Full Text] [Related]
70. A panel of microRNA signature in serum for colorectal cancer diagnosis. Zhu M, Huang Z, Zhu D, Zhou X, Shan X, Qi LW, Wu L, Cheng W, Zhu J, Zhang L, Zhang H, Chen Y, Zhu W, Wang T, Liu P. Oncotarget; 2017 Mar 07; 8(10):17081-17091. PubMed ID: 28177881 [Abstract] [Full Text] [Related]
71. Verification of the role of exosomal microRNA in colorectal tumorigenesis using human colorectal cancer cell lines. Noh GT, Kwon J, Kim J, Park M, Choi DW, Cho KA, Woo SY, Oh BY, Lee KY, Lee RA. PLoS One; 2020 Mar 07; 15(11):e0242057. PubMed ID: 33175885 [Abstract] [Full Text] [Related]
72. MicroRNA-223 functions as an oncogene in human colorectal cancer cells. Zhang J, Luo X, Li H, Yue X, Deng L, Cui Y, Lu Y. Oncol Rep; 2014 Jul 07; 32(1):115-20. PubMed ID: 24819398 [Abstract] [Full Text] [Related]
73. Plasma exosome microRNAs are indicative of breast cancer. Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ. Breast Cancer Res; 2016 Sep 08; 18(1):90. PubMed ID: 27608715 [Abstract] [Full Text] [Related]
74. Upregulation of MicroRNA 18b Contributes to the Development of Colorectal Cancer by Inhibiting CDKN2B. Li Y, Chen M, Liu J, Li L, Yang X, Zhao J, Wu M, Ye M. Mol Cell Biol; 2017 Nov 15; 37(22):. PubMed ID: 28784723 [Abstract] [Full Text] [Related]
75. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer. Panza A, Votino C, Gentile A, Valvano MR, Colangelo T, Pancione M, Micale L, Merla G, Andriulli A, Sabatino L, Vinciguerra M, Prattichizzo C, Mazzoccoli G, Colantuoni V, Piepoli A. Biochim Biophys Acta; 2014 Jun 15; 1843(6):1225-36. PubMed ID: 24631504 [Abstract] [Full Text] [Related]
76. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer. Vishnubalaji R, Hamam R, Abdulla MH, Mohammed MA, Kassem M, Al-Obeed O, Aldahmash A, Alajez NM. Cell Death Dis; 2015 Jan 22; 6(1):e1614. PubMed ID: 25611389 [Abstract] [Full Text] [Related]
77. Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes. Nakurte I, Jekabsons K, Rembergs R, Zandberga E, Abols A, Linē A, Muceniece R. Anticancer Res; 2018 Nov 22; 38(11):6133-6138. PubMed ID: 30396929 [Abstract] [Full Text] [Related]
78. The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer. Liu Y, Chen X, Cheng R, Yang F, Yu M, Wang C, Cui S, Hong Y, Liang H, Liu M, Zhao C, Ding M, Sun W, Liu Z, Sun F, Zhang C, Zhou Z, Jiang X, Chen X. Mol Cancer; 2018 Jan 19; 17(1):11. PubMed ID: 29351796 [Abstract] [Full Text] [Related]
79. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer. Yan S, Han B, Gao S, Wang X, Wang Z, Wang F, Zhang J, Xu D, Sun B. Oncotarget; 2017 Sep 01; 8(36):60149-60158. PubMed ID: 28947960 [Abstract] [Full Text] [Related]
80. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer. Hibner G, Kimsa-Furdzik M, Francuz T. Int J Mol Sci; 2018 Sep 27; 19(10):. PubMed ID: 30262723 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]